Drawing for LEXION

USPTO serial 76695756

LEXION

Reviewed by CopyMark Law Group

Reg. 3783102Status 710
Filing date
Status date
Registration date
May 4, 2010
Examiner
FOSDICK, GEOFFREY A
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with LEXION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Thomas N. Phung

THOMAS N. PHUNG Jacobson and Johnson1 WATER ST W STE 285SAINT PAUL, MN 55107-2080UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010surgical and medical apparatus, namely, catheters, compressors, and surgical compressorsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 9, 2016C8..CANCELLED SEC. 8 (6-YR)—
May 4, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 16, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 27, 2010NPUBNOTICE OF PUBLICATION—
Jan 12, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 11, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 8, 2010ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Dec 28, 2009PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Dec 14, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 14, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 14, 2009ACECAMENDMENT FROM APPLICANT ENTERED—
Dec 14, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 7, 2009MAILPAPER RECEIVED—
Jun 22, 2009CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 22, 2009CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 8, 2009ACECAMENDMENT FROM APPLICANT ENTERED—
Jun 8, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 5, 2009MAILPAPER RECEIVED—
Apr 21, 2009CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED—
Apr 21, 2009CEAPEXAMINER'S AMENDMENT/PRIORITY ACTION MAILED—
Apr 21, 2009CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Apr 20, 2009ALIEASSIGNED TO LIE—
Apr 20, 2009DOCKASSIGNED TO EXAMINER—
Feb 24, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 19, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance